cyclo-Tetrakis{μ-2,2′-dimethyl-1,1′-[2,2-bis(bromomethyl)propane-1,3-diyl]di(1H-benzimidazole)-κ2N3:N3′}tetrakis[bromidocopper(I)]

Abstract

The title compound, [Cu4Br4(C21H22Br2N4)4], features a macrocyclic Cu4L4 ring system in which each CuI atom is coordinated by one bromide ion and two N atoms from two 2,2′-dimethyl-1,1′-[2,2-bis(bromomethyl)propane-1,3-diyl]di(1H-benzimidazole) (L) ligands in a distorted trigonal–planar geometry. The L ligands adopt either a cis or trans configuration. The asymmetric unit contains one half-molecule with the center of the macrocycle located on a crystallographic center of inversion. Each bromide ion binds to a CuI atom in a terminal mode and is oriented outside the ring. The macrocycles are interconnected into a two-dimensional network by π–π interactions between benzimidazole groups from different rings [centroid–centroid distance = 3.803 (5) Å.